QV Bioelectronics

To add a bio or update company history, please click update information.

News from QV Bioelectronics

QV Bioelectronics raises £4.5m in funding led by PXN Ventures to treat brain cancer with implantable device

21 Jan 2026

QV Bioelectronics raises £4.5m in funding led by PXN Ventures to treat brain cancer with implantable device

QV Bioelectronics develops an implantable medical device that delivers therapeutic electric fields to residual brain cancer cells, aiming to reduce tumour regrowth following surgery for patients with glioblastoma.

QV Bioelectronics

Life Sciences
Cheshire, United Kingdom
£4.5m
qvbio.co.uk
Update Information

More venture news

RQ Bio
25 Jun 2026
RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
Series ALife Sciences
TRIMTECH Therapeutics
23 Jun 2026
TRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases
ExtensionLife Sciences
Houdini Bio
19 Jun 2026
Houdini Bio launches with a £1.5m pre-seed led by SCVC to tackle gene silencing with machine learning DNA design platform
Pre-seedLife Sciences

QV Bioelectronics

News from QV Bioelectronics

QV Bioelectronics raises £4.5m in funding led by PXN Ventures to treat brain cancer with implantable device

More venture news

RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza

TRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases

Houdini Bio launches with a £1.5m pre-seed led by SCVC to tackle gene silencing with machine learning DNA design platform